DE69018836T2 - Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält. - Google Patents

Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Info

Publication number
DE69018836T2
DE69018836T2 DE69018836T DE69018836T DE69018836T2 DE 69018836 T2 DE69018836 T2 DE 69018836T2 DE 69018836 T DE69018836 T DE 69018836T DE 69018836 T DE69018836 T DE 69018836T DE 69018836 T2 DE69018836 T2 DE 69018836T2
Authority
DE
Germany
Prior art keywords
substance
biological effect
intestinal mucosa
triglyzeride
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69018836T
Other languages
English (en)
Other versions
DE69018836D1 (de
Inventor
Sven Froekjaer
Tomas Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8148900&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69018836(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69018836D1 publication Critical patent/DE69018836D1/de
Application granted granted Critical
Publication of DE69018836T2 publication Critical patent/DE69018836T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69018836T 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält. Revoked DE69018836T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK657689A DK657689D0 (da) 1989-12-22 1989-12-22 Middel med biologisk virkning paa tarmslimhinden
PCT/DK1990/000343 WO1991009597A1 (en) 1989-12-22 1990-12-21 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent

Publications (2)

Publication Number Publication Date
DE69018836D1 DE69018836D1 (de) 1995-05-24
DE69018836T2 true DE69018836T2 (de) 1995-11-16

Family

ID=8148900

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69018836T Revoked DE69018836T2 (de) 1989-12-22 1990-12-21 Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.

Country Status (8)

Country Link
EP (1) EP0509009B1 (de)
JP (1) JPH05502669A (de)
AT (1) ATE121293T1 (de)
AU (1) AU638541B2 (de)
CA (1) CA2072010A1 (de)
DE (1) DE69018836T2 (de)
DK (2) DK657689D0 (de)
WO (1) WO1991009597A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2069073T3 (es) * 1989-04-07 1995-05-01 New England Deaconess Hospital Trigliceridos de cadena corta.
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
DE69403789T2 (de) * 1993-04-23 1997-12-04 Loders Croklaan Bv Nährfette mit verbesserter verdaulichkeit
EP0748196B1 (de) * 1994-03-01 2000-06-14 The Procter & Gamble Company Drei-zonen binde
EP0739589B1 (de) * 1995-04-28 2001-06-13 Loders Croklaan B.V. An polyungesättigten Fettsäuren reiche Triglyceride
US6410078B1 (en) 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
WO1997009978A1 (en) * 1995-09-13 1997-03-20 Morten Sloth Weidner Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
JP7482127B2 (ja) 2018-12-17 2024-05-13 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 食品用ブチレート

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE407180C (de) * 1920-04-25 1924-12-09 Wilhelm Normann Dr Verfahren zur Herstellung von gemischten Glyceriden
US2879281A (en) * 1955-06-29 1959-03-24 Eastman Kodak Co Trans esterification of triglycerides by means of plural metal catalyst
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
JPS6387988A (ja) * 1986-10-01 1988-04-19 Nisshin Oil Mills Ltd:The 消化吸収性の良い油脂
FR2617161B1 (fr) * 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention

Also Published As

Publication number Publication date
AU638541B2 (en) 1993-07-01
DK0509009T3 (da) 1995-08-07
JPH05502669A (ja) 1993-05-13
AU7046691A (en) 1991-07-24
EP0509009A1 (de) 1992-10-21
DK657689D0 (da) 1989-12-22
DE69018836D1 (de) 1995-05-24
WO1991009597A1 (en) 1991-07-11
CA2072010A1 (en) 1991-06-23
ATE121293T1 (de) 1995-05-15
EP0509009B1 (de) 1995-04-19

Similar Documents

Publication Publication Date Title
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
ATE7697T1 (de) Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES2168395T3 (es) Nueva formulacion antitrombotica, procedimiento para su preparacion y utilizacion de la misma.
ES2109945T3 (es) Composiciones y procedimientos para identificar moleculas biologicamente activas.
DE69027865T2 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
BR9403783A (pt) Uso de uma composição cosmética
ES2196082T3 (es) Analagos del factor de crecimiento de queratinocitos.
DE69018836T2 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ATE489T1 (de) Sila-substituierte 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung, arzneimittel und verfahren zu deren herstellung.
DE69104083T2 (de) Neue Antiulcus-Substanz.
ES2087279T3 (es) El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
ES2089157T3 (es) Nuevos derivados de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
AT399504B (de) Neue aminopropoxyimino-cycloalkanderivate, deren herstellung, arzneimittel, die diese verbindungen als wirkstoff enthalten sowie verfahren zur herstellung derselben
DE69124380T2 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten
FR2644459B1 (fr) Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ES2063056T3 (es) Esteres poliaromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
ES2089399T3 (es) Composicion para el tratamiento del cabello que contiene un compuesto de perfluoropolieter y un agente nacarante.
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE113290T1 (de) Nicht gesättigte cycloaliphatische ester von makroliden antibiotika und linkosamiden antibiotika, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen und kosmetischen zusammensetzungen.
FR2644460B1 (de)

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation